New TB vax safe, prompts immune response, early trials show

A novel vaccine against deadly tuberculosis (TB) has shown to be safe and effective, according to results of the Phase 1 clinical trial.Currently, Bacille Calmette-Guerin (BCG) is the most widely administered vaccine against TB across the ...

Related Keywords

New York ,United States ,Bacille Calmette Guerin , ,Nature Communications ,Saint Louis University Center ,Access To Advanced Health Institute ,Infectious Disease Research Institute In Seattle ,Vaccine Development ,Advanced Health Institute ,Infectious Disease Research Institute ,